Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases. It uses ImmunoTAC technology to create therapeutic molecules that can be systemically administered to patients and act only at the sites of disease, sparing healthy tissues from unwanted side effects